TRCT
SMTI icon

Tower Research Capital (TRC)’s Sanara MedTech SMTI Stock Holding History

Tower Research Capital (TRC)’s Portfolio SMTI Stock Details SMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.7K Sell
835
-66
-7% -$1.36K ﹤0.01% 3571
2026
Q1 		$15.5K Buy
901
+282
+46% +$5.8K ﹤0.01% 3664
2025
Q4 		$14.5K Buy
619
+252
+69% +$6.51K ﹤0.01% 3348
2025
Q3 		$11.6K Sell
367
-562
-60% -$17K ﹤0.01% 3865
2025
Q2 		$26.4K Buy
929
+551
+146% +$16.5K ﹤0.01% 3513
2025
Q1 		$11.7K Sell
378
-248
-40% -$8.42K ﹤0.01% 3516
2024
Q4 		$20.8K Buy
626
+302
+93% +$10.2K ﹤0.01% 3155
2024
Q3 		$9.8K Sell
324
-1,020
-76% -$31.8K ﹤0.01% 3831
2024
Q2 		$37.9K Buy
1,344
+1,107
+467% +$34.8K ﹤0.01% 3307
2024
Q1 		$8.77K Sell
237
-27
-10% -$1.01K ﹤0.01% 3967
2023
Q4 		$10.8K Sell
264
-533
-67% -$17.1K ﹤0.01% 4195
2023
Q3 		$24.8K Buy
797
+625
+363% +$24.2K ﹤0.01% 3180
2023
Q2 		$6.9K Sell
172
-297
-63% -$12.2K ﹤0.01% 4648
2023
Q1 		$19K Sell
469
-38
-7% -$1.6K ﹤0.01% 3508
2022
Q4 		$23K Buy
507
+153
+43% +$5.27K ﹤0.01% 3006
2022
Q3 		$11K Sell
354
-798
-69% -$22.3K ﹤0.01% 4463
2022
Q2 		$24K Buy
1,152
+842
+272% +$19.7K ﹤0.01% 3616
2022
Q1 		$9K Buy
310
+260
+520% +$6.59K ﹤0.01% 4489
2021
Q4 		$1K Sell
50
-96
-66% -$3.02K ﹤0.01% 5885
2021
Q3 		$5K Buy
+146
New +$5.24K ﹤0.01% 4886
2021
Q2 		– Sell
-393
Closed -$12K – 5812
2021
Q1 		$12K Buy
393
+83
+27% +$2.88K ﹤0.01% 4276
2020
Q4 		$15K Buy
+310
New +$12.2K ﹤0.01% 4060

Other funds holding SMTI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
SWM
Stonebridge Wealth Management Oak Brook, Illinois $112M AUM 23.07% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Tower Research Capital (TRC)'s SMTI Position: Q2 2026 in Review

Tower Research Capital (TRC) reduced its Sanara MedTech (SMTI) stake by 7.3% in Q2 2026, selling an estimated $1.36K and leaving 835 shares worth $19.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3571.

Tower Research Capital (TRC) first reported a position in SMTI in Q4 2020 and has held it in 22 quarters since. The position peaked at $37.9K in Q2 2024. 74 funds tracked by Wall St. Rank hold SMTI as of Q2 2026.

  • Tower Research Capital (TRC) held 835 shares of Sanara MedTech worth $19.7K as of Q2 2026.
  • Tower Research Capital (TRC) sold 66 Sanara MedTech shares in Q2 2026, an estimated $1.36K.
  • Sanara MedTech made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #3571 holding.
  • Tower Research Capital (TRC) first reported a position in Sanara MedTech in Q4 2020 and has held it in 22 quarters since.
  • Tower Research Capital (TRC)'s Sanara MedTech position peaked at $37.9K in Q2 2024.
  • 74 funds tracked by Wall St. Rank held Sanara MedTech as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.